(Q33347904)

26 July 2017

Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003. (English)

1 reference

26 July 2017

0 references

4

Frank Buntinx

1 reference

26 July 2017

Stefaan Bartholomeeusen

series ordinal

1

1 reference

PubMed ID

18590552

26 July 2017

Jan P Vandenbroucke

series ordinal

2

1 reference

PubMed ID

18590552

26 July 2017

Carla Truyers

series ordinal

3

1 reference

26 July 2017

30 June 2008

1 reference

26 July 2017

1 reference

26 July 2017

9

1 reference

26 July 2017

39

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

start time

30 June 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2296-9-39

0 references

cites work

Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

The importance of reaching lipid targets: statins and the prevention of atherosclerosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Sick individuals and sick populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Time trend analysis and variations in prescribing lipid lowering drugs in general practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Cholesterol and mortality. 30 years of follow-up from the Framingham study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Long-term outcome of cardiovascular prevention: a Nijmegen Academic Family Practices Network study

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-9-39

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-9-39

An analysis of first authorizations for lipid-lowering drugs in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-9-39

Age, sex and practice variations in the use of statins in general practice in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-9-39

Risk assessment and treatment of dyslipidemia in primary health care.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Global cardiovascular risk evaluation in Italy: a cross-sectional survey in general practice

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447840

Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice

31 October 2018

1 reference

12 December 2020

Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in The Netherlands

1 reference

12 December 2020

Hypercholesterolemia: case finding in family practice

1 reference

12 December 2020

An international glossary for general/family practice. WONCA Classification Committee

1 reference

12 December 2020

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

12 December 2020

The denominator in general practice, a new approach from the Intego database

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2296-9-39

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugi6jbal5ndk7devm34puikqma

30 July 2022

Dimensions Publication ID

1027371254

0 references

Fatcat ID

release_ugi6jbal5ndk7devm34puikqma

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugi6jbal5ndk7devm34puikqma

30 July 2022

https://api.fatcat.wiki/v0/release/ugi6jbal5ndk7devm34puikqma

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/ugi6jbal5ndk7devm34puikqma

1 reference

30 July 2022